UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The importance of understanding individual differences in Down syndrome [version 1; peer review: 2 approved]

F1000 research, 2016, Vol.5, p.389

2016

Volltextzugriff (PDF)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls

Journal of neurodevelopmental disorders, 2021-12, Vol.13 (1), p.1-48, Article 48

2021

Volltextzugriff (PDF)

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy

Psychopharmacologia, 2011-05, Vol.215 (1), p.105-115

2011

Volltextzugriff (PDF)

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome

Wellcome open research, 2016-11, Vol.1, p.11-11

2016

Volltextzugriff (PDF)

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome

Frontiers in psychology, 2019-01, Vol.9, p.2730-2730

2019

Volltextzugriff (PDF)

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome

Frontiers in psychiatry, 2019-04, Vol.10, p.158-158

2019

Volltextzugriff (PDF)

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

Annals of clinical and translational neurology, 2018-06, Vol.5 (6), p.741-751

2018

Volltextzugriff (PDF)

Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management”

Alzheimer's & dementia, 2019-09, Vol.15 (9), p.1238-1239

2019

Volltextzugriff (PDF)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

Journal of neurodevelopmental disorders, 2019-08, Vol.11 (1), p.20-20, Article 20

2019

Volltextzugriff (PDF)

USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1076-P1077

2017

Volltextzugriff (PDF)

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome

Cerebral cortex (New York, N.Y. 1991), 2019-05, Vol.29 (5), p.2279-2290

2019

Volltextzugriff (PDF)

The mismatch negativity as an index of cognitive impairment in adults with Down syndrome

Alzheimer's & dementia, 2023-12, Vol.19 (S17), p.n/a

2023

Volltextzugriff (PDF)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Molecular psychiatry, 2021-10, Vol.26 (10), p.5766-5788

2021

Volltextzugriff (PDF)

[P3–328]: USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

Alzheimer's & dementia, 2017-07, Vol.13 (7S_Part_22), p.P1076-P1077

2017

Volltextzugriff (PDF)

O4‐03‐05: LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER'S DISEASE IN DOWN SYNDROME

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_24), p.P1236-P1237

2019

Volltextzugriff (PDF)

LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER’S DISEASE IN DOWN SYNDROME

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P1236-P1237

2019

Volltextzugriff (PDF)

[P3–168]: GENETIC DISSECTION OF SEVERITY AND ONSET MODULATORS FOR ALZHEIMER's PATHOLOGY IN DOWN SYNDROME USING CELLULAR SYSTEMS

Alzheimer's & dementia, 2017-07, Vol.13 (7S_Part_20)

2017

Volltextzugriff (PDF)

P2‐119: DEMENTIA AMONG THOSE WITH DOWN SYNDROME: FOCUSED ASSOCIATION STUDY ON TRISOMY 21 SNPS

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_13), p.P714-P715

2018

Volltextzugriff (PDF)

DEMENTIA AMONG THOSE WITH DOWN SYNDROME: FOCUSED ASSOCIATION STUDY ON TRISOMY 21 SNPS

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P714-P715

2018

Volltextzugriff (PDF)

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome

Journal of clinical medicine, 2021-04, Vol.10 (9), p.1882

2021

Volltextzugriff (PDF)

O1‐08‐02: SEQUENCE OF COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME DURING PROGRESSION FROM PRECLINICAL TO PRODROMAL ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_4), p.P235-P236

2018

Volltextzugriff (PDF)

SEQUENCE OF COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME DURING PROGRESSION FROM PRECLINICAL TO PRODROMAL ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P235-P236

2018

Volltextzugriff (PDF)

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Molecular psychiatry, 2021-10, Vol.26 (10), p.5789-5789

2021

Volltextzugriff (PDF)

Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsResearch in context

EBioMedicine, 2023-08, Vol.94, p.104692

2023

Volltextzugriff (PDF)

GENETIC DISSECTION OF SEVERITY AND ONSET MODULATORS FOR ALZHEIMER’S PATHOLOGY IN DOWN SYNDROME USING CELLULAR SYSTEMS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P998-P999

2017

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The importance of understanding individual differences in Down syndrome [version 1; peer review: 2 approved]

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management”

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome

The mismatch negativity as an index of cognitive impairment in adults with Down syndrome

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

[P3–328]: USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

O4‐03‐05: LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER'S DISEASE IN DOWN SYNDROME

LONGITUDINAL COGNITIVE DECLINE AND PRODROMAL STAGING MODEL FOR ALZHEIMER’S DISEASE IN DOWN SYNDROME

[P3–168]: GENETIC DISSECTION OF SEVERITY AND ONSET MODULATORS FOR ALZHEIMER's PATHOLOGY IN DOWN SYNDROME USING CELLULAR SYSTEMS

P2‐119: DEMENTIA AMONG THOSE WITH DOWN SYNDROME: FOCUSED ASSOCIATION STUDY ON TRISOMY 21 SNPS

DEMENTIA AMONG THOSE WITH DOWN SYNDROME: FOCUSED ASSOCIATION STUDY ON TRISOMY 21 SNPS

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer's Disease in Down Syndrome

O1‐08‐02: SEQUENCE OF COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME DURING PROGRESSION FROM PRECLINICAL TO PRODROMAL ALZHEIMER'S DISEASE

SEQUENCE OF COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME DURING PROGRESSION FROM PRECLINICAL TO PRODROMAL ALZHEIMER'S DISEASE

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsResearch in context

GENETIC DISSECTION OF SEVERITY AND ONSET MODULATORS FOR ALZHEIMER’S PATHOLOGY IN DOWN SYNDROME USING CELLULAR SYSTEMS

Aktive Filter

Suchergebnisse filtern